RICONPHARMA LLC
FDA Approved Drugs

RICONPHARMA LLC

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued
  • Total Records 17
  • Latest Approval Date May 26, 2026
  • Data Source FDA
  • First Approval Date Nov 05, 2018
All
17
View
Discontinued
8
View
RX
9
View
Company Overview

Company

RICONPHARMA LLC

Country

U.S.A

Website

Email

Social Profiles

Company Snapshot

RICONPHARMA LLC

U.S.A

View on Map
FDA Approved Drug Records ( 17 records )
2024
03 Dec
RX Application: 217462

Drug Name

COLESTIPOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2024-12-03

217462 / 1

Active Ingredient

COLESTIPOL HYDROCHLORIDE

Application Number

217462

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2024-12-03

Regulatory Status

RX

2022
16 Jun
RX Application: 207802

Drug Name

FLUNISOLIDE

Product Number

1

Dosage Form

-

Strength

0.025MG/SPRAY

Approval Date

2022-06-16

207802 / 1

Active Ingredient

FLUNISOLIDE

Application Number

207802

Product Number

1

Dosage Form

-

Strength

0.025MG/SPRAY

Approval Date

2022-06-16

Regulatory Status

RX

2018
05 Nov
RX Application: 210918

Drug Name

ISOSORBIDE MONONITRATE

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2018-11-05

210918 / 1

Active Ingredient

ISOSORBIDE MONONITRATE

Application Number

210918

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2018-11-05

Regulatory Status

RX

2018
05 Nov
RX Application: 210918

Drug Name

ISOSORBIDE MONONITRATE

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2018-11-05

210918 / 2

Active Ingredient

ISOSORBIDE MONONITRATE

Application Number

210918

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2018-11-05

Regulatory Status

RX

2018
05 Nov
RX Application: 210918

Drug Name

ISOSORBIDE MONONITRATE

Product Number

3

Dosage Form

-

Strength

120MG

Approval Date

2018-11-05

210918 / 3

Active Ingredient

ISOSORBIDE MONONITRATE

Application Number

210918

Product Number

3

Dosage Form

-

Strength

120MG

Approval Date

2018-11-05

Regulatory Status

RX

2024
22 Nov
RX Application: 215796

Drug Name

OXCARBAZEPINE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2024-11-22

215796 / 1

Active Ingredient

OXCARBAZEPINE

Application Number

215796

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2024-11-22

Regulatory Status

RX

2024
22 Nov
RX Application: 215796

Drug Name

OXCARBAZEPINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2024-11-22

215796 / 2

Active Ingredient

OXCARBAZEPINE

Application Number

215796

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2024-11-22

Regulatory Status

RX

2024
22 Nov
RX Application: 215796

Drug Name

OXCARBAZEPINE

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2024-11-22

215796 / 3

Active Ingredient

OXCARBAZEPINE

Application Number

215796

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2024-11-22

Regulatory Status

RX

2020
24 Nov
RX Application: 212342

Drug Name

SCOPOLAMINE

Product Number

1

Dosage Form

-

Strength

1MG/72HR

Approval Date

2020-11-24

212342 / 1

Active Ingredient

SCOPOLAMINE

Application Number

212342

Product Number

1

Dosage Form

-

Strength

1MG/72HR

Approval Date

2020-11-24

Regulatory Status

RX

2025
22 Apr
Discontinued Application: 218444

Drug Name

SIPONIMOD

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE

Approval Date

2025-04-22

218444 / 1

Active Ingredient

SIPONIMOD

Application Number

218444

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE

Approval Date

2025-04-22

Regulatory Status

Discontinued

2025
22 Apr
Discontinued Application: 218444

Drug Name

SIPONIMOD

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-04-22

218444 / 2

Active Ingredient

SIPONIMOD

Application Number

218444

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-04-22

Regulatory Status

Discontinued

2025
22 Apr
Discontinued Application: 218444

Drug Name

SIPONIMOD

Product Number

3

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-04-22

218444 / 3

Active Ingredient

SIPONIMOD

Application Number

218444

Product Number

3

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-04-22

Regulatory Status

Discontinued

2026
26 May
Discontinued Application: 220041

Drug Name

TOPIRAMATE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2026-05-26

220041 / 1

Active Ingredient

TOPIRAMATE

Application Number

220041

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2026-05-26

Regulatory Status

Discontinued

2026
26 May
Discontinued Application: 220041

Drug Name

TOPIRAMATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2026-05-26

220041 / 2

Active Ingredient

TOPIRAMATE

Application Number

220041

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2026-05-26

Regulatory Status

Discontinued

2026
26 May
Discontinued Application: 220041

Drug Name

TOPIRAMATE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2026-05-26

220041 / 3

Active Ingredient

TOPIRAMATE

Application Number

220041

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2026-05-26

Regulatory Status

Discontinued

2026
26 May
Discontinued Application: 220041

Drug Name

TOPIRAMATE

Product Number

4

Dosage Form

-

Strength

150MG

Approval Date

2026-05-26

220041 / 4

Active Ingredient

TOPIRAMATE

Application Number

220041

Product Number

4

Dosage Form

-

Strength

150MG

Approval Date

2026-05-26

Regulatory Status

Discontinued

2026
26 May
Discontinued Application: 220041

Drug Name

TOPIRAMATE

Product Number

5

Dosage Form

-

Strength

200MG

Approval Date

2026-05-26

220041 / 5

Active Ingredient

TOPIRAMATE

Application Number

220041

Product Number

5

Dosage Form

-

Strength

200MG

Approval Date

2026-05-26

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    7 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    17 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
17 total
  • RX
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

COLESTIPOL HYDROCHLORIDE

Application Number

217462

Product Number

1

Active Ingredient

COLESTIPOL HYDROCHLORIDE

Dosage Form

-

Strength

1GM

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.